Vera Therapeutics CFO Sean Grant receives $2.1M in 2021
Vera Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 14, 2022
Vera Therapeutics reported fiscal year 2021 executive compensation information on April 14, 2022.
In 2021, three executives at Vera Therapeutics received on average a compensation package of $1.7M, a 48% decrease compared to previous year.
Average pay of disclosed executives at Vera Therapeutics
Sean Grant, Chief Financial Officer, received $2.1M in total. 85% of Grant's compensation, or $1.8M, was in option awards. Grant also received $60K in bonus, $68K in non-equity incentive plan, as well as $189K in salary.
Marshall Fordyce, Chief Executive Officer, received a compensation package of $1.5M, which decreased by 54% compared to previous year. 52% of the compensation package, or $770K, was in option awards.
Celia Lin, Chief Medical Officer, earned $1.4M in 2021.
Related executives
You may also like
Source: SEC filing on April 14, 2022.